VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome


Por: Lleo, A, Carmona-Iragui, M, Videla, L, Fernandez, S, Benejam, B, Pegueroles, J, Barroeta, I, Altuna, M, Valldeneu, S, Xiao, MF, Xu, DS, Nunez-Llaves, R, Querol-Vilaseca, M, Sirisi, S, Bejanin, A, Iulita, MF, Clarimon, J, Blesa, R, Worley, P, Alcolea, D, Fortea, J, Belbin, O

Publicada: 28 jun 2021
Resumen:
Background There is an urgent need for objective markers of Alzheimer's disease (AD)-related cognitive impairment in people with Down syndrome (DS) to improve diagnosis, monitor disease progression, and assess response to disease-modifying therapies. Previously, GluA4 and neuronal pentraxin 2 (NPTX2) showed limited potential as cerebrospinal fluid (CSF) markers of cognitive impairment in adults with DS. Here, we compare the CSF profile of a panel of synaptic proteins (Calsyntenin-1, Neuroligin-2, Neurexin-2A, Neurexin-3A, Syntaxin-1B, Thy-1, VAMP-2) to that of NPTX2 and GluA4 in a large cohort of subjects with DS across the preclinical and clinical AD continuum and explore their correlation with cognitive impairment. Methods We quantified the synaptic panel proteins by selected reaction monitoring in CSF from 20 non-trisomic cognitively normal controls (mean age 44) and 80 adults with DS grouped according to clinical AD diagnosis (asymptomatic, prodromal AD or AD dementia). We used regression analyses to determine CSF changes across the AD continuum and explored correlations with age, global cognitive performance (CAMCOG), episodic memory (modified cued-recall test; mCRT) and CSF biomarkers, CSF A beta(42:40) ratio, CSF A beta(1-42), CSF p-tau, and CSF NFL. P values were adjusted for multiple testing. Results In adults with DS, VAMP-2 was the only synaptic protein to correlate with episodic memory (delayed recall adj.p = .04) and age (adj.p = .0008) and was the best correlate of CSF A beta(42:40) (adj.p = .0001), p-tau (adj.p < .0001), and NFL (adj.p < .0001). Compared to controls, mean VAMP-2 levels were lower in asymptomatic adults with DS only (adj.p = .02). CSF levels of Neurexin-3A, Thy-1, Neurexin-2A, Calysntenin-1, Neuroligin-2, GluA4, and Syntaxin-1B all strongly correlated with NPTX2 (p < .0001), which was the only synaptic protein to show reduced CSF levels in DS at all AD stages compared to controls (adj.p < .002). Conclusion These data show proof-of-concept for CSF VAMP-2 as a potential marker of synapse degeneration that correlates with CSF AD and axonal degeneration markers and cognitive performance.

Filiaciones:
Lleo, A:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Carmona-Iragui, M:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

 Fundacio Catalana Sindrome, Barcelona Med Ctr, Barcelona, Spain

Videla, L:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

 Fundacio Catalana Sindrome, Barcelona Med Ctr, Barcelona, Spain

Fernandez, S:
 Fundacio Catalana Sindrome, Barcelona Med Ctr, Barcelona, Spain

Benejam, B:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Fundacio Catalana Sindrome, Barcelona Med Ctr, Barcelona, Spain

Pegueroles, J:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Barroeta, I:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Altuna, M:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Valldeneu, S:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Xiao, MF:
 Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA

Xu, DS:
 Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA

Nunez-Llaves, R:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Querol-Vilaseca, M:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Sirisi, S:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Bejanin, A:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Iulita, MF:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

Clarimon, J:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Blesa, R:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Worley, P:
 Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA

 Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA

Alcolea, D:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Fortea, J:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain

Belbin, O:
 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Memory Unit, C Sant Quinti 77-79, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Hosp Santa Creu & Sant Pau, Biomed Res Inst Sant Pau IIB Sant Pau, Neurol Dept, C Sant Quinti 77-79, Barcelona 08025, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28031, Spain
ISSN: 17589193





Alzheimers Research & Therapy
Editorial
BMC, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 13 Número: 1
Páginas:
WOS Id: 000667679100001
ID de PubMed: 34183050
imagen Green Published, gold

MÉTRICAS